A study to determine if addition of oral medication is better than topical medication alone in treatment of hand and foot eczema
Phase 3
- Conditions
- Health Condition 1: L208- Other atopic dermatitis
- Registration Number
- CTRI/2021/11/037761
- Lead Sponsor
- AIIMS JODHPUR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient with clinical features included in proposed definition.
2.Patients with involvement of palms or soles or both palms and soles. (U/L or B/L)
3.Duration of disease > 6 weeks.
4.KOH negativity in U/L cases
Exclusion Criteria
1.Patients having active psoriasis elsewhere in body
2.Patients having characteristic nail findings of psoriasis
3.Refusing to consent
4.Clinically suspected or patch test positive cases of allergic contact dermatitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HECSI <br/ ><br>Timepoint: monthly
- Secondary Outcome Measures
Name Time Method VAS for itching <br/ ><br>â??QOLEHQâ?? questionnaire for quality of life. <br/ ><br>Patient global assessment <br/ ><br>Physician global assessmentTimepoint: MONTHLY